Free Trial

Alliance Pharma (LON:APH) Stock Price Up 0.8% - Still a Buy?

Alliance Pharma logo with Medical background

Alliance Pharma plc (LON:APH - Get Free Report)'s stock price shot up 0.8% during trading on Friday . The company traded as high as GBX 45.45 ($0.55) and last traded at GBX 44.35 ($0.54). 567,091 shares changed hands during mid-day trading, an increase of 0% from the average session volume of 567,058 shares. The stock had previously closed at GBX 44 ($0.54).

Alliance Pharma Price Performance

The firm has a market cap of £329.92 million, a PE ratio of -1,017.18, a PEG ratio of 1.04 and a beta of 0.67. The firm has a fifty day simple moving average of GBX 46.10 and a two-hundred day simple moving average of GBX 41.94. The company has a debt-to-equity ratio of 47.46, a quick ratio of 1.42 and a current ratio of 2.93.

Alliance Pharma Company Profile

(Get Free Report)

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.

Read More

Should You Invest $1,000 in Alliance Pharma Right Now?

Before you consider Alliance Pharma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alliance Pharma wasn't on the list.

While Alliance Pharma currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

How To Invest in Crypto as A Complete BEGINNER in 2025
3 AI Bargain Stocks to BUY NOW After the DeepSeek Crash
NVIDIA Stock Under Pressure: DeepSeek and the AI Tech War

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines